毒理學藥物篩選市場－全球產業規模、佔有率、趨勢、機會和預測，按檢測類型、產品、應用、地區和競爭格局分類，2020-2030年預測

全球毒理學藥物篩選市場規模將從2024年的121.6億美元成長到2030年的198.4億美元，複合年成長率（CAGR）為8.50%。毒理學藥物篩選是指在藥物發現和開發的初期階段，系統性地評估新型藥物化合物對生物系統的潛在不良反應。該市場的成長主要得益於全球藥物研發投入的不斷攀升，而這要求在進入臨床試驗之前進行嚴格的安全性評估。

主要市場促進因素

全球毒理學藥物篩選市場的擴張受到製藥研發投入不斷成長的顯著影響。隨著製藥公司投入大量資金用於新藥的發現和開發，全面、早期毒性評估的重要性也日益凸顯。

主要市場挑戰

影響全球毒理學藥物篩選市場的關鍵挑戰因素在於，開發和驗證能夠準確預測體內人體毒性的體外模型極為複雜且成本高昂。這直接阻礙了市場擴張，為先進篩選技術的廣泛應用設置了重大障礙。

主要市場趨勢

全球毒理學藥物篩選市場受到複雜體外模型（例如晶片器官和3D細胞培養技術）進步的顯著影響。與傳統的2D細胞培養相比，這些模型具有更高的生理相關性，能夠更精確地模擬人體生物學和藥物反應。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球毒理學藥物篩選市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依測試類型（體外、體內、電腦模擬）
  • 依產品分類（儀器、試劑及耗材、動物模型、軟體、其他產品）
  • 依應用（免疫毒性、全身毒性、發育和生殖毒性 (DART)、內分泌干擾、其他）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美毒理學藥物篩選市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲毒理學藥物篩選市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區毒理學藥物篩選市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲毒理學藥物篩選市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲毒理學藥物篩選市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球毒理學藥物篩選市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Promega Corporation
• The Jackson Laboratory

第16章：策略建議

第17章調查會社について,免責事項

The Global Toxicology Drug Screening Market will grow from USD 12.16 Billion in 2024 to USD 19.84 Billion by 2030 at a 8.50% CAGR. Toxicology drug screening involves the systematic evaluation of potential adverse effects of novel pharmaceutical compounds on biological systems during the initial stages of drug discovery and development. This market's expansion is fundamentally propelled by escalating global pharmaceutical research and development expenditures, which necessitate rigorous safety assessments before advancing to clinical trials.

Key Market Drivers

The expansion of the global toxicology drug screening market is significantly influenced by increasing pharmaceutical research and development investments. As pharmaceutical companies commit substantial capital to the discovery and development of novel drug candidates, the imperative for comprehensive and early-stage toxicity assessment grows. This commitment is exemplified by major industry players.

Key Market Challenges

A key challenging factor impacting the global toxicology drug screening market is the considerable complexity and inherent costs associated with developing and validating *in vitro* models that accurately forecast *in vivo* human toxicity. This directly hampers market expansion by creating significant barriers to the widespread adoption of advanced screening technologies. Pharmaceutical companies face substantial financial outlays in both the initial development and the subsequent rigorous validation required to ensure these *in vitro* models reliably predict human physiological responses.

Key Market Trends

The global toxicology drug screening market is significantly shaped by advancements in complex in vitro models, such as organ-on-a-chip and 3D cell culture technologies. These models offer enhanced physiological relevance compared to traditional 2D cell cultures, providing a more accurate representation of human biology and drug responses. Their adoption helps to reduce reliance on animal testing and can improve the predictive accuracy of preclinical toxicity assessments.

Key Market Players

• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Charles River Laboratories International, Inc.
• Enzo Life Sciences Inc.
• Eurofins Scientific SE
• Danaher Corporation
• Laboratory Corporation of America Holdings
• Promega Corporation
• The Jackson Laboratory

Report Scope:

In this report, the Global Toxicology Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Toxicology Drug Screening Market, By Testing Type:

• In Vitro
• In Vivo
• In Silico

Toxicology Drug Screening Market, By Product:

• Instruments
• Reagents and Consumables
• Animal Models
• Software
• Other Products

Toxicology Drug Screening Market, By Application:

• Immunotoxicity
• Systemic toxicity
• Developmental and Reproductive Toxicity (DART)
• Endocrine Disruption
• Other

Toxicology Drug Screening Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Toxicology Drug Screening Market.

Available Customizations:

Global Toxicology Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Toxicology Drug Screening Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Testing Type (In Vitro, In Vivo, In Silico)
  • 5.2.2. By Product (Instruments, Reagents and Consumables, Animal Models, Software, Other Products)
  • 5.2.3. By Application (Immunotoxicity, Systemic toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Toxicology Drug Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Testing Type
  • 6.2.2. By Product
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Toxicology Drug Screening Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Testing Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Toxicology Drug Screening Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Testing Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Toxicology Drug Screening Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Testing Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Application

7. Europe Toxicology Drug Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Testing Type
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Toxicology Drug Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Testing Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Application
  • 7.3.2. France Toxicology Drug Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Testing Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Toxicology Drug Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Testing Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Toxicology Drug Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Testing Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Toxicology Drug Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Testing Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Application

8. Asia Pacific Toxicology Drug Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Testing Type
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Toxicology Drug Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Testing Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Application
  • 8.3.2. India Toxicology Drug Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Testing Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Toxicology Drug Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Testing Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Toxicology Drug Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Testing Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Toxicology Drug Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Testing Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Application

9. Middle East & Africa Toxicology Drug Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Testing Type
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Toxicology Drug Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Testing Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Toxicology Drug Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Testing Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Toxicology Drug Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Testing Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Application

10. South America Toxicology Drug Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Testing Type
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Toxicology Drug Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Testing Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Toxicology Drug Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Testing Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Toxicology Drug Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Testing Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Toxicology Drug Screening Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Bio-Rad Laboratories, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies, Inc.
• 15.3. Merck KGaA
• 15.4. Charles River Laboratories International, Inc.
• 15.5. Enzo Life Sciences Inc.
• 15.6. Eurofins Scientific SE
• 15.7. Danaher Corporation
• 15.8. Laboratory Corporation of America Holdings
• 15.9. Promega Corporation
• 15.10. The Jackson Laboratory

16. Strategic Recommendations

17. About Us & Disclaimer